Authors
Latest:
Persistence With Mirabegron Versus Tolterodine in Patients With Overactive BladderIn a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Latest:
The Drug Pricing Debate Is Finally Shining a Light on Pharmacy Benefit ManagersThere have been several recent federal efforts aimed at bringing more balance into the market by increasing PBM oversight.
Latest:
Successful Collaborative Care Strategies for PharmacistsThe panel concludes its discussion with insights on successful strategies that can inform optimal collaborative care practices for cardiovascular risk reduction in patients with ASCVD.
Latest:
Medical Channel Management ProgramsSpecialty medication management programs offer plan sponsors a way to rein in costs, uncover hidden drug charges, and close the "oversight gap."
Latest:
Fosfomycin UseFosfomycin (Monurol) is an antibiotic that uses a unique mechanism of action to establish its bactericidal activity.
Latest:
Managing Inventory Well Is a Critical FunctionA new year is a great time to take on this task, which helps maximize cash flow and contributes to overall patient safety.
Latest:
The 7 Habits of Highly Effective Pharmacy Students and InternsCan we teach effective habits? Is there a blueprint for helping pharmacy students and interns be more proactive, prioritize more efficiently, and embrace a strong work ethic?
Latest:
The Role of the Specialty Pharmacist in Treating Colorectal CancerPharmacists are a rich resource, not only in the management of colorectal cancer, but in every aspect of health care.
Latest:
Evaluating Allergic Rhinitis in the Convenient Health Care Clinic: Treatment Strategies for Clinicians and PharmacistsThis Continuing Education activity is supported by an educational grant from McNeil Consumer Healthcare Division.
Latest:
Cannabidiol Presents ConundrumsRecent federal legalization and increases sales of CBD underscore the importance of considering its pharmacologic impact.
Latest:
Cannabidiol Products' Impact on Pharmacist-Provided Medication ManagementPharmacists can assist with advising patients who present with quality concerns to use CBD products that provide certificates of analyses, and catch significant drug interactions before they occur.
Latest:
Formulary Coverage for Antihypertensive Drugs Used in ChildrenDifferences in formulary coverage of antihypertensive medications for children between private and public insurance plans may impact physician prescribing practices and patient outcomes.
Latest:
Outcomes of a Specialty Pharmacy Program for Oral Oncology MedicationsOur research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.
Latest:
Treatment of ESBL-producing E coli Lower Urinary Tract InfectionA case involving a 43-year-old female with a history of type 2 diabetes who is admitted for hyperglycemia as well as complaints of dysuria and increased urinary frequency.
Latest:
Novel Tactics: Deterring Opioid AbuseSince the introduction of the new formulation of OxyContin, drug makers have sought innovative ways to curb the abuse of painkillers.
Latest:
Concepts in Acute Migraine Management: Clinical and Managed Care PerspectivesPatients, payers, providers, and employers are affected by misdiagnosis, undertreatment, and inappropriate management of migraine.
Latest:
Leveraging the Rise of Wearables and Digital Devices to Collect Patient Data for WellnessA veritable digital health revolution is brewing, with a plethora of health apps coming to market that go beyond simply tracking your daily steps and caloric burn.
Latest:
Comparing Direct Medical Costs of OnabotulinumtoxinA With Other Common Overactive Bladder InterventionsThis cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.
Latest:
Evidence-Based Adherence Classes for Combination Antihypertensive, Lipid-Lowering, and Antidiabetic TherapyAdherence classes were determined for patients taking multiple medications (ie, lipid-lowering, antihypertensive, antidiabetic) and were found to be related to serum profiles and risk of adverse events.
Latest:
Improving Outcomes: Providing Care for Patients with Mental IllnessBehavioral health pharmacy can utilize an embedded co-management model.
Latest:
Diabetes Increases Risk of Some Dermatologic ConditionsSkin complications are often the first sign of the disease, but they can be prevented and treated when caught early.
Latest:
Understanding the Veterinary PatientCurrently pharmacists and pharmacy technicians have little to no formal education regarding our veterinary patients, although our responsibility to them is the same as our human patients.
Latest:
Cost-Effectiveness of Medication Therapy Management in Part D Diabetic EnrolleesPharmacist-delivered medication therapy management is a cost-effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk diabetic Medicare patients.
Latest:
Clinical Studies for Closed-System Transfer Devices: Yes, They MatterClosed-system transfer devices are an integral component in reducing occupational exposure to hazardous drugs.
Latest:
Roundup: Reviewing the Pharmacotherapy of AMI in the Health SystemMortality rates for acute myocardial infarction have decreased, but rapid response and chronic management are key to improving outcomes.
Latest:
Cost Implications of Early Treatment Initiation Among Patients With Newly Diagnosed FibromyalgiaInitiation of treatment with guideline-recommended medications within 60 days of fibromyalgia diagnosis was associated with immediate annual healthcare cost savings.
Latest:
Synergies in Specialty: The 3 P's of Specialty Pharmacy--Pharmacy, Payer, and ProductIn the development of a specialty pharmacy strategy, there are many key stakeholders, but none more important than the pharmacy, payer, and product. Each has its own mission and goals; however, at some point they must all come together.
